Retraction “Methylation of the MAOA promoter is associated with schizophrenia”
Retraction

Retraction “Methylation of the MAOA promoter is associated with schizophrenia”

Hao Yang1,2, Jiajue Li1,2, Aicen Ji1,2, Liping Hu2, Xiufeng Zhang2, Linlin Liu2, Lili Qing1,2, Ming Yan1,2, Shengjie Nie2

1Kunming Medical University, Kunming, China;2Department of Forensic Medicine, Kunming Medical University, Kunming, China

Correspondence to: Shengjie Nie. Department of Forensic Medicine, Kunming Medical University, Kunming, China. Email: 931386066@qq.com.

doi: 10.21037/atm-2020-42

Retraction to: Ann Transl Med 2020;8(14):864

The article entitled “Methylation of the MAOA promoter is associated with schizophrenia”, published in the Issue 14, Vol. 8 of Annals of Translational Medicine (1) is being retracted on the ground of incomplete sample data. The authors apologize and regret for the inconvenience caused.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

References

  1. Yang H, Li J, Ji A, et al. Methylation of the MAOA promoter is associated with schizophrenia. Ann Transl Med 2020;8:864. [Crossref] [PubMed]
Cite this article as: Yang H, Li J, Ji A, Hu L, Zhang X, Liu L, Qing L, Yan M, Nie S. Retraction “Methylation of the MAOA promoter is associated with schizophrenia”. Ann Transl Med 2020;8(22):1555. doi: 10.21037/atm-2020-42

Article Options

Download Citation

Share